Severe Obesity as an Independent Risk Factor for COVID-19 Mortality in Hospitalized Patients Younger than 50
- PMID: 32445512
- PMCID: PMC7283736
- DOI: 10.1002/oby.22913
Severe Obesity as an Independent Risk Factor for COVID-19 Mortality in Hospitalized Patients Younger than 50
Abstract
Objective: Coronavirus disease 2019 (COVID-19) continues to spread, and younger patients are also being critically affected. This study analyzed obesity as an independent risk factor for mortality in hospitalized patients younger than 50.
Methods: This study retrospectively analyzed data of patients with COVID-19 who were hospitalized to a large academic hospital system in New York City between March 1, 2020, and May 17, 2020. Data included demographics, comorbidities, BMI, and smoking status. Obesity groups included the following: BMI of 30 to < 40 kg/m2 and BMI ≥ 40 kg/m2 . Multivariable logistic regression models identified variables independently associated with mortality in patients younger and older than 50.
Results: Overall, 3,406 patients were included; 572 (17.0%) patients were younger than 50. In the younger age group, 60 (10.5%) patients died. In the older age group, 1,076 (38.0%) patients died. For the younger population, BMI ≥ 40 was independently associated with mortality (adjusted odds ratio 5.1; 95% CI: 2.3-11.1). For the older population, BMI ≥ 40 was also independently associated with mortality to a lesser extent (adjusted odds ratio 1.6; 95% CI: 1.2-2.3).
Conclusions: This study demonstrates that hospitalized patients younger than 50 with severe obesity are more likely to die of COVID-19. This is particularly relevant in the Western world, where obesity rates are high.
© 2020 The Obesity Society.
Conflict of interest statement
The authors declared no conflict of interest.
Figures
Similar articles
-
Severe obesity, increasing age and male sex are independently associated with worse in-hospital outcomes, and higher in-hospital mortality, in a cohort of patients with COVID-19 in the Bronx, New York.Metabolism. 2020 Jul;108:154262. doi: 10.1016/j.metabol.2020.154262. Epub 2020 May 16. Metabolism. 2020. PMID: 32422233 Free PMC article.
-
Preadmission Diabetes-Specific Risk Factors for Mortality in Hospitalized Patients With Diabetes and Coronavirus Disease 2019.Diabetes Care. 2020 Oct;43(10):2339-2344. doi: 10.2337/dc20-1543. Epub 2020 Aug 7. Diabetes Care. 2020. PMID: 32769128 Free PMC article.
-
Risk Factors for Hospitalization and Mortality due to COVID-19 in Espírito Santo State, Brazil.Am J Trop Med Hyg. 2020 Sep;103(3):1184-1190. doi: 10.4269/ajtmh.20-0483. Am J Trop Med Hyg. 2020. PMID: 32682453 Free PMC article.
-
Impact of obesity on hospitalizations and mortality, due to COVID-19: A systematic review.Obes Res Clin Pract. 2020 Sep-Oct;14(5):398-403. doi: 10.1016/j.orcp.2020.07.005. Epub 2020 Jul 23. Obes Res Clin Pract. 2020. PMID: 32736969 Free PMC article.
-
Obesity: A critical risk factor in the COVID-19 pandemic.Clin Obes. 2020 Dec;10(6):e12403. doi: 10.1111/cob.12403. Epub 2020 Aug 28. Clin Obes. 2020. PMID: 32857454 Free PMC article. Review.
Cited by
-
Diabetes and Overweight/Obesity Are Independent, Nonadditive Risk Factors for In-Hospital Severity of COVID-19: An International, Multicenter Retrospective Meta-analysis.Diabetes Care. 2021 Jun;44(6):1281-1290. doi: 10.2337/dc20-2676. Epub 2021 Apr 15. Diabetes Care. 2021. PMID: 33858854 Free PMC article.
-
Obesity in patients with COVID-19: a systematic review and meta-analysis.Metabolism. 2020 Dec;113:154378. doi: 10.1016/j.metabol.2020.154378. Epub 2020 Sep 28. Metabolism. 2020. PMID: 33002478 Free PMC article.
-
Obesity as a Risk Factor for Complications and Mortality in Individuals with SARS-CoV-2: A Systematic Review.Nutrients. 2024 Feb 16;16(4):543. doi: 10.3390/nu16040543. Nutrients. 2024. PMID: 38398867 Free PMC article.
-
Obesity and Coronavirus Disease 2019.J Metab Bariatr Surg. 2021 Jun;10(1):1-8. doi: 10.17476/jmbs.2021.10.1.1. Epub 2021 Jun 30. J Metab Bariatr Surg. 2021. PMID: 36687755 Free PMC article. Review.
-
Roles of host mitochondria in the development of COVID-19 pathology: Could mitochondria be a potential therapeutic target?Mol Biomed. 2021 Nov 23;2:38. doi: 10.1186/s43556-021-00060-1. eCollection 2021 Dec. Mol Biomed. 2021. PMID: 34841263 Free PMC article. Review.
References
-
- Centers for Disease Control and Prevention . Coronavirus disease 2019 (COVID‐19): cases in the U.S. Published 2020. Accessed May 4, 2020. https://www.cdc.gov/coronavirus/2019‐ncov/cases‐updates/cases‐in‐us.html
MeSH terms
LinkOut - more resources
Full Text Sources
Other Literature Sources